Lung Cancer
An open-label, randomized study of BMS-986489 (atigotatug + nivolumab fixed-dose combination) vs durvalumab as consolidation therapy following chemoradiotherapy in limited-stage small-cell lung cancer (TIGOS-LS) (CA245-0004)
- Details
ClinicalTrials.gov ID:
NCT06773910
Diagnosis Type:
NA
USOR Number:
- Address
,
P: